Differential effects of chronic naltrexone treatment on food intake patterns and body weight in rats depend on their food deprivation status. 2011

Eliana Barrios De Tomasi, and Jorge Juárez
Laboratorio de Farmacología y Conducta, Instituto de Neurociencias, Universidad de Guadalajara, Guadalajara, Jalisco, CP 44130, Mexico.

The aim of the present study was to assess the effect of chronic naltrexone treatment on daily patterns of food intake in food-deprived and free-feeding rats. In experiment 1, Wistar male rats had continuous access to food and water, while in experiment 2 they were deprived of food for 12h/day. Animals in both experiments were studied as follows: a baseline period (7days), followed by a treatment period (14days) with either saline or naltrexone at 10mg/kg/day. Finally, a post-treatment period (7days) was assessed. Food and water consumption were measured every 2h after the naltrexone or saline injection for 12h and once more 12h later. Experiment 1: Food intake was higher in the naltrexone group 10h after injection. Total food intake and body weight gain were higher in the naltrexone group than in the saline group in the second week of treatment and in the post-treatment period. Experiment 2: The overeating observed in the saline group in the hours following the 12h of the food deprivation period was suppressed by naltrexone, though total daily food intake was not affected. Body weight gain was initially reduced by naltrexone, but a rebound effect was observed during the post-treatment period in the naltrexone group. Naltrexone produced a differential effect on food intake and body weight that depended on the rats' food deprivation status. These results could be explained in terms of opioid receptor up-regulation that enhances the rewarding effects of food or by naltrexone-produced changes in palatability.

UI MeSH Term Description Entries
D008297 Male Males
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005508 Food Deprivation The withholding of food in a structured experimental situation. Deprivation, Food,Deprivations, Food,Food Deprivations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Eliana Barrios De Tomasi, and Jorge Juárez
September 2012, Journal of psychopharmacology (Oxford, England),
Eliana Barrios De Tomasi, and Jorge Juárez
January 1983, The International journal of neuroscience,
Eliana Barrios De Tomasi, and Jorge Juárez
March 2010, Pharmacology, biochemistry, and behavior,
Eliana Barrios De Tomasi, and Jorge Juárez
January 2003, Physiology & behavior,
Eliana Barrios De Tomasi, and Jorge Juárez
May 1987, Pharmacology, biochemistry, and behavior,
Eliana Barrios De Tomasi, and Jorge Juárez
October 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Eliana Barrios De Tomasi, and Jorge Juárez
January 1987, General pharmacology,
Eliana Barrios De Tomasi, and Jorge Juárez
January 1990, Pharmacological research,
Eliana Barrios De Tomasi, and Jorge Juárez
April 1994, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!